Project Details
Description
PROJECT SUMMARY
The COVID-19 pandemic has cast a heavy burden on individuals with HIV infection. Based on data of 15,522
hospitalized patients with the coinfection of HIV and SARS-CoV-2 from 24 countries, a recent World Health
Organization (WHO) report for the first time confirmed that HIV to be an independent risk factor for severe
COVID-19. Despite a generally high risk of severe COVID-19 clinical course in individuals with HIV, the
interactions between SARS-CoV-2 and HIV infections remain unclear. For example, the severity of COVID-19 in
individuals with HIV is correlated with certain comorbidities in which some of these comorbidities are more
prevalent in patients with HIV than other populations. Yet, several contradictory findings suggested the
predominant role of comorbidities in the severity of COVID-19 regardless of HIV infection. Individuals with low
CD4+ T-cell count (e.g.,
| Status | Finished |
|---|---|
| Effective start/end date | 7/13/22 → 6/30/24 |
Funding
- National Institute of Allergy and Infectious Diseases: $222,943.00